Safety and efficacy of lamotrigine in subjects 1-24 months of age with partial seizures-double-blind phase results

被引：0
|
作者：
Piña-Garza, JE
Levisohn, P
Gucuyener, K
Turkey, A
Mikati, M
Lebanon, B
Warnock, CR
Messenheimer, J
机构：
来源：
NEUROLOGY | 2005年 / 64卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A117 / A117
页数：1
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF ADJUNCTIVE BRIVARACETAM FOR PARTIAL-ONSET (FOCAL) SEIZURES: POOLED RESULTS FROM THREE FIXED-DOSE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDIES
    Quarato, P. P.
    Whitesides, J.
    D'Souza, J.
    Johnson, M. E.
    Schiemann, J.
    EPILEPSIA, 2015, 56 : 208 - 209
  • [32] Developmental Outcomes at 24 Months of Age in Toddlers Supplemented with Arachidonic Acid and Docosahexaenoic Acid: Results of a Double Blind Randomized, Controlled Trial
    Devlin, Angela M.
    Chau, Cecil M. Y.
    Dyer, Roger
    Matheson, Julie
    McCarthy, Deanna
    Yurko-Mauro, Karin
    Innis, Sheila M.
    Grunau, Ruth E.
    NUTRIENTS, 2017, 9 (09)
  • [33] A Randomized, Double-blind, Phase 2a Clinical Trial to Study the Efficacy and Safety of Lamotrigine for Treatment of Patients with Dementia with Lewy Bodies
    Xi, T.
    Kang, S.
    Kim, F.
    Schindler, A.
    Greeley, D.
    Choung, J.
    Yun, M.
    Ye, B.
    MOVEMENT DISORDERS, 2024, 39 : S295 - S296
  • [34] Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: Results from phase 1 and 2 studies
    Uchiyama, Makoto
    Mishima, Kazuo
    Yagi, Tomoko
    Yoshihara, Tatsuya
    Eto, Takashi
    Muehlan, Clemens
    Togo, Osamu
    Inoue, Yuichi
    JOURNAL OF SLEEP RESEARCH, 2025, 34 (01)
  • [35] EFFICACY AND SAFETY OF BENRALIZUMAB IN ADULTS AND ADOLESCENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 24-WEEK DOUBLE-BLIND PERIOD OF THE PHASE 3 MESSINA TRIAL
    Rothenberg, Marc E.
    Dellon, Evan S.
    Collins, Margaret H.
    Bredenoord, Albert J.
    Hirano, Ikuo
    Peterson, Kathryn A.
    Brooks, Laura
    Fjallbrant, Harald
    Grindebacke, Hanna K.
    Ho, Calvin N.
    Keith, Matthew
    McCrae, Christopher
    White, Wendy
    Datto, Catherine
    GASTROENTEROLOGY, 2023, 164 (06) : S114 - S115
  • [36] Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
    Ostor, Andrew
    Van den Bosch, Filip
    Papp, Kim
    Asnal, Cecilia
    Blanco, Ricardo
    Aelion, Jacob
    Alperovich, Gabriela
    Lu, Wenjing
    Wang, Zailong
    Soliman, Ahmed M.
    Eldred, Ann
    Barcomb, Lisa
    Kivitz, Alan
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (03) : 351 - 358
  • [37] EFFICACY AND SAFETY OF PERAMPANEL AS ADJUNCTIVE THERAPY IN ADOLESCENTS WITH REFRACTORY PARTIAL-ONSET SEIZURES: ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY
    Villanueva, V.
    Rozentals, G.
    Yang, H.
    Squillacote, D.
    Zhu, J.
    Laurenza, A.
    EPILEPSIA, 2011, 52 : 242 - 242
  • [38] EFFICACY AND SAFETY OF ESLICARBAZEPINE ACETATE AS ADD-ON TREATMENT IN PATIENTS WITH PARTIAL-ONSET SEIZURES: POOLED ANALYSIS OF THREE DOUBLE-BLIND PHASE III CLINICAL STUDIES
    Elger, C.
    French, J.
    Halasz, P.
    Ben-Menachem, Elinor
    Gabbai, A. A.
    Lopes-Lima, J.
    Gil-Nagel, Antonio
    Maia, Joana
    Almeida, L.
    Soares-da-Silva, Patricio
    EPILEPSIA, 2008, 49 : 428 - 429
  • [39] Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
    Dandona, Paresh
    Mathieu, Chantai
    Phillip, Moshe
    Hansen, Lars
    Griffen, Steven C.
    Tschope, Diethelm
    Thoren, Fredrik
    Xu, John
    Langkilde, Anna Maria
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (11): : 864 - 876
  • [40] Dose-dependent safety and efficacy of zonisamide: A randomized, double-blind, placebo-controlled study in patients with refractory partial seizures
    Brodie, MJ
    Duncan, T
    Vespignani, H
    Solyom, A
    Bitenskyy, V
    Lucas, C
    EPILEPSIA, 2005, 46 (01) : 31 - 41
12345